Permanent leadless cardiac pacing: Results of the LEADLESS trial

Circulation

Volumn 129, Issue 14, 2014, Pages 1466-1471

  Reddy, Vivek Y ^a   Knops, Reinoud E ^b   Sperzel, Johannes ^c   Miller, Marc A ^a   Petru, Jan ^d   Simon, Jaroslav ^d   Sediva, Lucie ^d   De Groot, Joris R ^b   Tjong, Fleur V Y ^b   Jacobson, Peter ^e   Ostrosff, Alan ^e   Dukkipati, Srinivas R ^a   Koruth, Jacob S ^a   Wilde, Arthur A M ^b   Kautzner, Josef ^f   Neuzil, Petr ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Kerckhoff Heart and Thorax Center   (Germany)

^d NA HOMOLCE HOSPITAL   (Czech Republic)

^e Nanostim Inc   (United States)

^f INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

pacemaker, cardiac

Indexed keywords

HEPARIN;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; BRAIN INFARCTION; CARDIOPULMONARY BYPASS; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COMPLETE HEART BLOCK; CONTROLLED STUDY; DEVICE SAFETY; FAINTNESS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART PACING; HEART TAMPONADE; HEART VENTRICLE PERFORATION; HEMIPLEGIA; HUMAN; LEADLESS CARDIAC PACEMAKER; LIMITED MOBILITY; MALE; MONOMORPHIC VENTRICULAR TACHYCARDIA; MULTICENTER STUDY; PACEMAKER ELECTRODE; PACEMAKER PROGRAMMER; PATENT FORAMEN OVALE; PERCUTANEOUS DRAINAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SECOND DEGREE ATRIOVENTRICULAR BLOCK; SINUS RHYTHM; STERNOTOMY; TREATMENT INDICATION; TREATMENT OUTCOME; VERY ELDERLY;

CARDIAC; PACEMAKER;

AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; COHORT STUDIES; EQUIPMENT DESIGN; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84898046591     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.006987     Document Type: Article

References (24)

1. th world survey of cardiac pacing and implantable cardioverter-defbrillators: calendar year 2009-a World Society of Arrhythmia's project. Pacing Clin Electrophysiol. 2011;34:1013-1027.
2. Udo EO, Zuithoff NP, van Hemel NM, de Cock CC, Hendriks T, Doevendans PA, Moons KG. Incidence and predictors of short-and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm. 2012;9:728-735.
3. Hauser RG, Hayes DL, Kallinen LM, Cannom DS, Epstein AE, Almquist AK, Song SL, Tyers GF, Vlay SC, Irwin M. Clinical experience with pacemaker pulse generators and transvenous leads: an 8-year prospective mul-ticenter study. Heart Rhythm. 2007;4:154-160. (Pubitemid 46158694)
4. Haghjoo M, Nikoo MH, Fazelifar AF, Alizadeh A, Emkanjoo Z, Sadr-Ameli MA. Predictors of venous obstruction following pacemaker or implantable cardioverter-defbrillator implantation: a contrast venographic study on 100 patients admitted for generator change, lead revision, or device upgrade. Europace. 2007;9:328-332. (Pubitemid 47079254)
5. Tobin K, Stewart J, Westveer D, Frumin H. Acute complications of permanent pacemaker implantation: their fnancial implication and relation to volume and operator experience. Am J Cardiol. 2000;85:774-6, A9. (Pubitemid 30133406)
6. Vardas PE, Politopoulos C, Manios E, Parthenakis F, Tsagarkis C. A miniature pacemaker introduced intravenously and implanted endocardi-ally. Preliminary fndings from an experimental study. Eur J Card Pacing Electrophysiol. 1991;1:1-47.
7. Spickler JW, Rasor NS, Kezdi P, Misra SN, Robins KE, LeBoeuf C. Totally self-contained intracardiac pacemaker. J Electrocardiol. 1970;3:325-331.
8. Gillis AM, Russo AM, Ellenbogen KA, Swerdlow CD, Olshansky B, Al-Khatib SM, Beshai JF, McComb JM, Nielsen JC, Philpott JM, Shen WK. HRS/ACCF expert consensus statement on pacemaker device and mode selection. J Am Coll Cardiol. 2012;60:682-703.
9. Provenier F, Jordaens L. Evaluation of six minute walking test in patients with single chamber rate responsive pacemakers. Br Heart J. 1994;72:192-196. (Pubitemid 24251476)
10. Sugiura T, Nakamura Y, Mizushina S, Hasegawa T, Yoshimura K, Harada Y. A temperature-sensitive cardiac pacemaker. J Med Eng Technol. 1983;7:21-23. (Pubitemid 13139389)
11. Alt E, Hirgstetter C, Heinz M, Blömer H. Rate control of physiologic pacemakers by central venous blood temperature. Circulation. 1986;73:1206-1212. (Pubitemid 16080533)
12. Van Gelder BM, Bracke FA, Oto A, Yildirir A, Haas PC, Seger JJ, Stainback RF, Botman KJ, Meijer A. Diagnosis and management of inadvertently placed pacing and ICD leads in the left ventricle: a multi-center experience and review of the literature. Pacing Clin Electrophysiol. 2000;23:877-883. (Pubitemid 30331749)
13. Bohnen M, Stevenson WG, Tedrow UB, Michaud GF, John RM, Epstein LM, Albert CM, Koplan BA. Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias. Heart Rhythm. 2011;8:1661-1666.
14. Gammage MD, Lieberman RA, Yee R, Manolis AS, Compton SJ, Khazen C, Schaaf K, Oleson KA, Crossley GH; Worldwide SelectSecure Clinical Investigators. Multi-center clinical experience with a lumenless, catheter-delivered, bipolar, permanent pacemaker lead: implant safety and electrical performance. Pacing Clin Electrophysiol. 2006;29:858-865. (Pubitemid 44222139)
15. Lee KL. In the wireless era: leadless pacing. Expert Rev Cardiovasc Ther. 2010;8:171-174.
16. Maisel WH, Hauser RG, Hammill SC, Hauser RG, Ellenbogen KA, Epstein AE, Hayes DL, Alpert JS, Berger RD, Curtis AB, Dubin AM, Estes NA 3rd, Gura MT, Krahn AD, Lampert R, Lindsay BD, Wilkoff BL; Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines; American College of Cardiology (ACC); American Heart Association (AHA). Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines: developed in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Heart Rhythm. 2009;6:869-885.
17. Kirkfeldt RE, Johansen JB, Nohr EA, Moller M, Arnsbo P, Nielsen JC. Risk factors for lead complications in cardiac pacing: a population-based cohort study of 28, 860 Danish patients. Heart Rhythm. 2011;8:1622-1628.
18. Al-Mohaissen MA, Chan KL. Prevalence and mechanism of tricuspid regurgitation following implantation of endocardial leads for pacemaker or cardioverter-defbrillator. J Am Soc Echocardiogr. 2012;25:245-252.
19. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, Theuns D, Park RE, Wright DJ, Connelly DT, Fynn SP, Murgatroyd FD, Sperzel J, Neuzner J, Spitzer SG, Ardashev AV, Oduro A, Boersma L, Maass AH, Van Gelder IC, Wilde AA, van Dessel PF, Knops RE, Barr CS, Lupo P, Cappato R, Grace AA. An entirely subcutaneous implantable cardioverter-defbrillator. N Engl J Med. 2010;363:36-44.
20. Birnie DH, Healey JS, Wells GA, Verma A, Tang AS, Krahn AD, Simpson CS, Ayala-Paredes F, Coutu B, Leiria TL, Essebag V; BRUISE CONTROL Investigators. Pacemaker or defbrillator surgery without interruption of anticoagulation. N Engl J Med. 2013;368:2084-2093.
21. Lee KL, Lau CP, Tse HF, Echt DS, Heaven D, Smith W, Hood M. First human demonstration of cardiac stimulation with transcutaneous ultrasound energy delivery: implications for wireless pacing with implantable devices. J Am Coll Cardiol. 2007;50:877-883. (Pubitemid 47268744)
22. Wieneke H, Konorza T, Erbel R, Kisker E. Leadless pacing of the heart using induction technology: a feasibility study. Pacing Clin Electrophysiol. 2009;32:177-183.
23. Auricchio A, Delnoy PP, Regoli F, Seifert M, Markou T, Butter C; collaborative study group. First-in-man implantation of leadless ultrasound-based cardiac stimulation pacing system: novel endocar-dial left ventricular resynchronization therapy in heart failure patients. Europace. 2013;15:1191-1197.
24. Benditt DG, Goldstein M, Belalcazar A. The leadless ultrasonic pacemaker: a sound idea? Heart Rhythm. 2009;6:749-751.